ArticleFrontiers in physiology2026
Ea/Ees and oscillatory power fraction capture complementary but distinct components of ventriculoarterial coupling: a porcine study.
Article in Frontiers in physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Ventriculoarterial coupling (VAC), traditionally assessed using the invasive "gold standard" Ea/Ees ratio (arterial elastance to end-systolic elastance), is clinically important but requires approximations that are impractical at the bedside. Oscillatory power fraction (OPF), defined as the ratio of oscillatory to total hydraulic power and derived from synchronized aortic flow-pressure measurements, has been proposed as a pragmatic VAC surrogate. This study aimed to clarify the possible correlation between VAC and OPF in pharmacologically induced hemodynamic extremes. Methods: In 14 juvenile pigs challenged with vasoactive (phenylephrine, nitroprusside) and cardioactive drugs (dobutamine, esmolol) titrated toward protocolized targets (± 40% MAP, ± 50% d Results: Ea/Ees changed by 10%-36% across the four interventions, whereas OPF changed by 1.5%-12%, and under phenylephrine and dobutamine, the change in OPF was negligible (| Conclusion: Ea/Ees and OPF are not interchangeable. OPF responded far less strongly than Ea/Ees to the loading changes imposed here and did not resolve them under two of the four challenges. This is consistent with the two indices reflecting predominantly steady and pulsatile aspects of arterial load, although the present data do not demonstrate that separation directly. While OPF cannot replace Ea/Ees, power-derived indices offer practical adjuncts for characterizing ventriculoarterial interactions and the effects of selected drugs at the intensive care bedside.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.